½ÃÀ庸°í¼­
»óǰÄÚµå
1599621

¿©¼º¿ë µðÁöÅÐ Çコ ½ÃÀå : À¯Çüº°, À¯Åë ä³Îº°, ¿ëµµº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Women¢¥s Digital Health Market by Type (Diagnostic Tools, Mobile Apps, Wearable Devices), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), Application - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 185 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¿©¼º¿ë µðÁöÅÐ Çコ ½ÃÀåÀº 2023³â 53¾ï 9,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 60¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¬Æò±Õ 12.74% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 124¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¿©¼º¿ë µðÁöÅÐ Çコ´Â ¿©¼º ƯÀ¯ÀÇ °Ç°­ ¿ä±¸¿Í °æÇèÀ» ÃæÁ·½Ã۱â À§ÇØ Æ¯º°È÷ °í¾ÈµÈ ±â¼ú·Î ±¸ÇöµÈ Á¾ÇÕÀûÀÎ °Ç°­°ü¸® ¼Ö·ç¼ÇÀ» ¸»ÇÕ´Ï´Ù. ¿©±â¿¡´Â »ý½Ä °Ç°­, ¸ðÀÚ °Ç°­, È£¸£¸ó °Ç°­, Á¤½Å°Ç°­, ¿©¼º¿¡°Ô ÈçÇÑ ¸¸¼ºÁúȯ °ü¸® µîÀÌ Æ÷ÇԵ˴ϴÙ. °³ÀÎÈ­µÇ°í Á¢±ÙÇϱ⠽¬¿î ÇコÄÉ¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¿©¼ºÀ» À§ÇÑ µðÁöÅÐ °Ç°­ ÀÌ´Ï¼ÅÆ¼ºêÀÇ Çʿ伺ÀÌ °­Á¶µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â ¿ø°Ý °Ç°­, ¸ð¹ÙÀÏ °Ç°­ ¿ëµµ, ¿þ¾î·¯ºí °Ç°­ ±â±â, AI ±â¹Ý Áø´Ü¿¡ Àû¿ëµÇ¸ç, ÁÖ¿ä ÃÖÁ¾»ç¿ëÀÚ´Â º´¿ø, Ŭ¸®´Ð, ¿Ü·¡ ȯÀÚ ¹× ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü ¸ðµÎ¿¡ ÇØ´çÇÕ´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â ¸¸¼ºÁúȯ À¯º´·ü Áõ°¡, ¿¹¹æÀû °Ç°­°ü¸®¿¡ ´ëÇÑ °ü½É Áõ°¡, ÀΰøÁö´É ¹× ¸Ó½Å·¯´×°ú °°Àº ±â¼ú ¹ßÀüÀÌ ²ÅÈü´Ï´Ù. µðÁöÅÐ Çコ Åø¿¡ ´ëÇÑ Àνİú ¼ö¿ëµµ°¡ ³ô¾ÆÁö¸é¼­ ½º¸¶Æ®Æù°ú ÀÎÅÍ³Ý ¿¬°áÀÇ È®»ê°ú ÇÔ²² ÀÌ·¯ÇÑ Ãß¼¼°¡ ´õ¿í °­È­µÇ°í ÀÖ½À´Ï´Ù. ±âȸ´Â ƯÈ÷ ÀÇ·á ¼­ºñ½º°¡ ÃæºÐÇÏÁö ¾ÊÀº Áö¿ª°ú Àü ¼¼°è °÷°÷ÀÇ ¹ÌÃæÁ· ÀÇ·á ¼ö¿ä¿Í Á¤½Å°Ç°­ ¼Ö·ç¼Ç°ú ´Ù¸¥ ÀÇ·á ¼­ºñ½º¿ÍÀÇ ÅëÇÕ¿¡¼­ ãÀ» ¼ö ÀÖ½À´Ï´Ù. ÀÌ º¸°í¼­´Â »ç¿ëÀÚ Ä£È­ÀûÀ̰í, ¹®È­ÀûÀ¸·Î ¹Î°¨Çϸç, ÇÁ¶óÀ̹ö½Ã¸¦ °í·ÁÇÑ Çõ½Å¿¡ ÃÊÁ¡À» ¸ÂÃâ °ÍÀ» Á¦¾ÈÇÕ´Ï´Ù. ±×·¯³ª µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ¹®Á¦, ±ÔÁ¦ Áؼö, ±â¼ú ÀÎÇÁ¶ó °ÝÂ÷ µîÀÇ ¹®Á¦°¡ ¼ºÀåÀÇ °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÇコÄɾ ´ëÇÑ Á¢±Ù¼º °ÝÂ÷°¡ ½ÃÀå ħÅõ¸¦ Á¦ÇÑÇÒ °¡´É¼ºµµ ÀÖ½À´Ï´Ù. Çõ½ÅÀÌ °¡Àå ±â´ëµÇ´Â ºÐ¾ß·Î´Â AI¸¦ Ȱ¿ëÇÑ Áúº´ Á¶±â ¹ß°ßÀ» À§ÇÑ ¿¹Ãø ºÐ¼®, À¯ÀüüÇÐÀ» Ȱ¿ëÇÑ ¸ÂÃãÇü Ä¡·á °èȹ, ´Ù¾çÇÑ µðÁöÅÐ ¼Ò½ºÀÇ °Ç°­ µ¥ÀÌÅ͸¦ ÅëÇÕÇÏ¿© Á¾ÇÕÀûÀÎ Ä¡·á ¼Ö·ç¼ÇÀ» Á¦°øÇÏ´Â °Í µîÀÌ ÀÖ½À´Ï´Ù. ¿¬±¸ °³¹ßÀº ¿©¼ºÀÇ »ý¹°ÇÐÀ» ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ´Â ¾Ë°í¸®ÁòÀ» °³¹ßÇϰųª °»³â±â ¹× ¿ù°æ °Ç°­°ú °°Àº ƯÁ¤ ¹®Á¦¸¦ ÇØ°áÇÏ´Â µ¥ ÃÊÁ¡À» ¸ÂÃâ ¼ö ÀÖ½À´Ï´Ù. ±Þ¼ÓÇÑ ±â¼ú ¹ßÀü°ú Ä¡¿­ÇÑ °æÀïÀÌ Æ¯Â¡ÀÎ ÀÌ ½ÃÀåÀº ¿©¼º °Ç°­À» À§ÇÑ ¸ÂÃãÇü µðÁöÅÐ ¼Ö·ç¼Ç¿¡ ÅõÀÚÇÒ ÀÇÁö°¡ ÀÖ´Â ½ºÅ¸Æ®¾÷°ú ±âÁ¸ ±â¾÷¿¡°Ô Å« ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 53¾ï 9,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 60¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 124¾ï 9,000¸¸ ´Þ·¯
CAGR(%) 12.74%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ¿©¼º¿ë µðÁöÅÐ Çコ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¿©¼º¿ë µðÁöÅÐ Çコ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ëÀ» ÅëÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¸¹Àº ¿©¼º Àα¸¿¡¼­ °¨¿° ¹× ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡
    • ¿©¼º °Ç°­ ÁõÁøÀ» À§ÇÑ µðÁöÅÐ °Ç°­ ±â¼ú µµÀÔ Áõ°¡
    • µðÁöÅÐ Çコ ¾Û ¹× ¸ð¹ÙÀÏ Áø´Ü µµ±¸¿¡ ´ëÇÑ ÅõÀÚ ¹× ±ÔÁ¦ Ȱµ¿ Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ÀϺΠ½ÅÈï °æÁ¦±¹ÀÇ ÀνÄ, ±³À° ¹× Á¤º¸ ºÎÁ·
  • ½ÃÀå ±âȸ
    • ¿©¼º °Ç°­ ¼­ºñ½º¿¡ ´ëÇÑ ÀÎ½Ä ¹× Á¢±Ù¼º Çâ»ó
    • ¿©¼º °Ç°­À» À§ÇÑ Çù·ÂÀû ³ë·Â Áõ°¡
  • ½ÃÀå °úÁ¦
    • µ¥ÀÌÅÍÀÇ ÇÁ¶óÀ̹ö½Ã ¹× º¸¾È¿¡ ´ëÇÑ ¿ì·Á

Porter's Five Forces : ¿©¼º¿ë µðÁöÅÐ Çコ ½ÃÀå °ø·«À» À§ÇÑ Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲÀÇ °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¿©¼º¿ë µðÁöÅÐ Çコ ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿©¼º¿ë µðÁöÅÐ Çコ ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¿©¼º¿ë µðÁöÅÐ Çコ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ÀÖ¾î ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ¿©¼º¿ë µðÁöÅÐ Çコ ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆÄ¾Ç

¿©¼º¿ë µðÁöÅÐ Çコ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ º¥´õÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ¿©¼º¿ë µðÁöÅÐ Çコ ½ÃÀå¿¡¼­ÀÇ º¥´õ ¼º°ú Æò°¡

¿©¼º¿ë µðÁöÅÐ Çコ ½ÃÀå¿¡¼­ÀÇ º¥´õ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¿©¼º¿ë µðÁöÅÐ Çコ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÒ ¼ö ÀÖ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¿©¼º¿ë µðÁöÅÐ Çコ ½ÃÀå¿¡¼­ ¼º°øÇϱâ À§ÇÑ Àü·« ºÐ¼® ¹× ±ÇÀå »çÇ×

¿©¼º¿ë µðÁöÅÐ Çコ ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·®, ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀº °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ ü°è¸¦ ±¸ÃàÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ¿©¼º¿ë µðÁöÅÐ Çコ ½ÃÀå : À¯Çüº°

  • Áø´Ü Åø
  • ¸ð¹ÙÀÏ ¾Û
  • ¿þ¾î·¯ºí µð¹ÙÀ̽º

Á¦7Àå ¿©¼º¿ë µðÁöÅÐ Çコ ½ÃÀå : À¯Åë ä³Îº°

  • º´¿ø ¾à±¹
  • ¿Â¶óÀÎ ¾à±¹
  • ¼Ò¸Å ¾à±¹

Á¦8Àå ¿©¼º¿ë µðÁöÅÐ Çコ ½ÃÀå : ¿ëµµº°

  • ÀϹÝÀûÀÎ ÇコÄɾî¿Í °Ç°­
  • °ñ¹Ý Äɾî
  • ÀӽŰú °£È£
  • »ý½Ä¿¡ °üÇÑ °Ç°­

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ¿©¼º¿ë µðÁöÅÐ Çコ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¿©¼º¿ë µðÁöÅÐ Çコ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¿©¼º¿ë µðÁöÅÐ Çコ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦12Àå °æÀï »óȲ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Agile Therapeutics Inc
  • Amgen Inc.
  • Bayer AG
  • BioWink GmbH
  • Eli Lilly and Company
  • Fitbit, Inc.
  • Flo Health, Inc.
  • HeraMED Limited
  • Johnson & Johnson Services, Inc
  • Koninklijke Philips N.V.
  • Leap Fitness Group
  • MobileODT Ltd.
  • Novartis AG
  • Ovuline, Inc.
  • Prima-Temp, Inc.
ksm 24.12.04

The Women's Digital Health Market was valued at USD 5.39 billion in 2023, expected to reach USD 6.05 billion in 2024, and is projected to grow at a CAGR of 12.74%, to USD 12.49 billion by 2030.

Women's Digital Health refers to the comprehensive range of healthcare solutions enabled through technology that are designed specifically to address the unique health needs and experiences of women. This includes reproductive health, maternal and child health, hormonal health, mental health, and management of chronic diseases common among women. The rising demand for personalized and accessible healthcare solutions underlines the necessity of women's digital health initiatives. These tools find applications in telehealth, mobile health applications, wearable health devices, and AI-based diagnostics, catering to both consumers and healthcare providers in hospitals, clinics, and outpatient care as primary end-users. Key growth factors include the increasing prevalence of chronic conditions, heightened focus on preventive healthcare, and technological advancements such as artificial intelligence and machine learning. The growing awareness and acceptance of digital health tools, coupled with the proliferation of smartphones and internet connectivity, strengthen this trend. Opportunities lie in unmet medical needs, particularly within underserved rural and global regions, and in integrating mental health solutions with other health services. Recommendations suggest focusing on user-friendly, culturally sensitive, and privacy-conscious innovations. However, challenges such as data privacy concerns, regulatory compliance, and technological infrastructure disparities pose hurdles to growth. Additionally, disparities in healthcare access may limit market penetration. The most promising areas for innovation include AI-driven predictive analytics for early disease detection, personalized treatment plans using genomics, and the integration of health data from various digital sources to offer comprehensive care solutions. Research efforts could focus on developing algorithms that better understand female biology or address specific issues like menopause and menstrual health. The market, characterized by rapid technological advances and increasing competition, presents a robust potential for startups and established companies willing to invest in tailored digital solutions for women's health.

KEY MARKET STATISTICS
Base Year [2023] USD 5.39 billion
Estimated Year [2024] USD 6.05 billion
Forecast Year [2030] USD 12.49 billion
CAGR (%) 12.74%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Women's Digital Health Market

The Women's Digital Health Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of infectious and chronic diseases amongst a large pool of female population
    • Rising adoption of digital health technologies to improve women's health
    • Increasing investments and regulatory activities towards digital health apps and portable diagnostic tools
  • Market Restraints
    • Lack of awareness, eduction, and information in some under-developing economies
  • Market Opportunities
    • Rise in awareness and accessibility of women's health offerings
    • Upsurge in the collaborative efforts to address women's health
  • Market Challenges
    • Concerns regarding data privacy and security

Porter's Five Forces: A Strategic Tool for Navigating the Women's Digital Health Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Women's Digital Health Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Women's Digital Health Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Women's Digital Health Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Women's Digital Health Market

A detailed market share analysis in the Women's Digital Health Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Women's Digital Health Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Women's Digital Health Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Women's Digital Health Market

A strategic analysis of the Women's Digital Health Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Women's Digital Health Market, highlighting leading vendors and their innovative profiles. These include Agile Therapeutics Inc, Amgen Inc., Bayer AG, BioWink GmbH, Eli Lilly and Company, Fitbit, Inc., Flo Health, Inc., HeraMED Limited, Johnson & Johnson Services, Inc, Koninklijke Philips N.V., Leap Fitness Group, MobileODT Ltd., Novartis AG, Ovuline, Inc., and Prima-Temp, Inc..

Market Segmentation & Coverage

This research report categorizes the Women's Digital Health Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Diagnostic Tools, Mobile Apps, and Wearable Devices.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Application, market is studied across General Healthcare & Wellness, Pelvic Care, Pregnancy & Nursing Care, and Reproductive Health.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of infectious and chronic diseases amongst a large pool of female population
      • 5.1.1.2. Rising adoption of digital health technologies to improve women's health
      • 5.1.1.3. Increasing investments and regulatory activities towards digital health apps and portable diagnostic tools
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of awareness, eduction, and information in some under-developing economies
    • 5.1.3. Opportunities
      • 5.1.3.1. Rise in awareness and accessibility of women's health offerings
      • 5.1.3.2. Upsurge in the collaborative efforts to address women's health
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns regarding data privacy and security
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Women's Digital Health Market, by Type

  • 6.1. Introduction
  • 6.2. Diagnostic Tools
  • 6.3. Mobile Apps
  • 6.4. Wearable Devices

7. Women's Digital Health Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Hospital Pharmacies
  • 7.3. Online Pharmacies
  • 7.4. Retail Pharmacies

8. Women's Digital Health Market, by Application

  • 8.1. Introduction
  • 8.2. General Healthcare & Wellness
  • 8.3. Pelvic Care
  • 8.4. Pregnancy & Nursing Care
  • 8.5. Reproductive Health

9. Americas Women's Digital Health Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Women's Digital Health Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Women's Digital Health Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agile Therapeutics Inc
  • 2. Amgen Inc.
  • 3. Bayer AG
  • 4. BioWink GmbH
  • 5. Eli Lilly and Company
  • 6. Fitbit, Inc.
  • 7. Flo Health, Inc.
  • 8. HeraMED Limited
  • 9. Johnson & Johnson Services, Inc
  • 10. Koninklijke Philips N.V.
  • 11. Leap Fitness Group
  • 12. MobileODT Ltd.
  • 13. Novartis AG
  • 14. Ovuline, Inc.
  • 15. Prima-Temp, Inc.
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦